Lanyan Fang, PhD

Deputy Director
US Food and Drug Administration

Dr. Lanyan (Lucy) Fang serves as Deputy Director of the Division of Quantitative Methods and Modeling (DQMM), Office of Research and Standards, Office of Generic Drugs (OGD), CDER/FDA. She has established herself as the FDA expert in the use of quantitative clinical pharmacology approaches in the product life cycle management. Prior to her OGD career, Lucy worked as senior clinical pharmacology reviewer in the FDA’s Office of Clinical Pharmacology and senior pharmacokinetist in Merck. Lucy obtained her PhD in Pharmaceutical Sciences from The Ohio State University and is a graduate of the Excellence in Government Fellows program (2014-2015).

Presentation(s):

• Revolutionizing End-to-End Drug Discovery, Development, and Clinical Utilization Through Quantitative Medicine co-sponsored by ASCPT and ISoP

  Saturday, May 31, 2025
  8:30 AM - 3:00 PM East Coast USA Time